3D bioprinting systems (patent granted) which can rapidly and accurately produce 3D tissue cell models for drug discovery and regenerative medicine. Cardiac and cancer modelling.
About
Ground breaking 3D bioprinting systems with unique and proven design based on microvalve and inkjet technology for more accurate printing of human tissue models. Patent granted in Europe and the USA.
Key Benefits
Printing of high cell densities in gels typically 8 times more dense models for more accurate 3D models of tissue. Ability to print tissue materials for implanting in orthopaedic and regenerative medicine applications, Printing on almost any substrate for wider application range.
User-friendly, compact 3D bioprinters for printing of single or multi-materials, low risk due to well-established supply chain of componentry used to manufacture Jetbio 3D bioprinters.
Applications
Accelerate drug discovery process for faster and lower cost pharma therapeutics and regenerative medicine applications. Proven for pre-clinical applications in cardiac, cancer modelling (leukaemia) and orthopaedics.